The FDA requires injectable peptide drug products to be tested for aggregationspecifically the formation of dimers and trimers from monomeric peptide in solution
Therapy should therefore not be discontinued in patients with established CVD who do not achieve the weight-loss targets observed in clinical trials
Global GLP-1 market Here, Novo is not only the market leader but also holds more than 50% of the market
Judy Cho Judy Cho, BCHN, FNTP is board certified in holistic nutrition and a certified functional nutritional therapy practitioner
Follow-up visits at 48 week intervals during dose escalation allow for adverse effect monitoring and dose adjustment
According to a TGA spokesperson, its development as a potential medicine was halted some years ago due to safety reasons. And yet, some Australians continue to use Melanotan-II for tanning, despite continued warnings from the TGA